{"database": "lobbying", "table": "lobbying_activities", "rows": [[1007692, "31b03ed6-ff6d-49c3-8871-ef8e512a4ed1", "Q3", "WINSTON & STRAWN LLP", 41682, "FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC )", 2010, "third_quarter", "PHA", "Represent the client on issues related to assuring a safe, reliable supply of heparin and also patent matters, including settlements.  Legislation of interest includes the FY 2011 Financial Services Appropriations Bill (S. 3677), the FY 2010 Supplemental Appropriations Bill (H.R. 4899; P.L. 111-212), and the Preserve Access to Affordable Generics Act (S. 369).", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2010-10-19T18:27:45.003000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1007692"], "units": {}, "query_ms": 2.751805994194001, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}